Here we show that the mutational inactivation of Sesn2 protects mice against developing cigarette smoke-induced pulmonary emphysema.
Studies of documents from the tobacco industry have shown how cigarette branding has been used to target a particular consumer group, how branding may increase the appeal of smoking, 2– 4 and how considerable efforts have been put into developing cigarette packet designs that attract the consumers.
It claims instead that its money is better spent on research and development, through which it can develop safer cigarettes and a "hard tobacco product".
Gregory N. Connolly of the Harvard School of Public Health says FDA should focus on reducing tobacco use, rather than regulating the industry's efforts to develop "safer" cigarettes.
Analyses verified that the method utilized to develop SC cigarettes yielded consistent, concentration-dependent products within 25% of the expected concentrations.
To develop a cigarette smoking challenge model in patients with COPD with an aim to utilise this in therapeutic trials of novel therapeutic agents.
We aimed to develop a cigarette-smoke-induced emphysema mouse model in which serial lung function and muscular dysfunction could be assessed, allowing the disease to be monitored more appropriately.
Realizing this, a Chinese company has developed electronic cigarettes, which fully replicate the act of smoking, complete with a physical cigarette, vapor and the satisfying, um, smoking part.
In particular, BAT developed elastic cigarettes that produced low yields under standard testing protocols, whereas in consumers' hands they elicited more intensive smoking and provided higher concentrations of tar and nicotine to smokers.
The company says it is willing to work with federal regulators to define and develop a "safer" cigarette, remove harmful ingredients from cigarettes and keep tobacco out of the hands of teenagers, even if that means fewer adults smoke in the future.
